Logos Global Management LP Repare Therapeutics Inc. Transaction History

Logos Global Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.22 - $11.79 $966,000 - $3.54 Million	300,000 Added 100.0%	600,000 $4.38 Million
Q3 2023 Nov 14, 2023	BUY	$8.16 - $13.01 $2.45 Million - $3.9 Million	300,000 New	300,000 $3.62 Million
Q1 2022 May 16, 2022	SELL	$11.38 - $21.88 $19.3 Million - $37.2 Million	-1,700,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$19.66 - $28.11 $33 Million - $47.2 Million	1,680,000 Added 8400.0%	1,700,000 $35.9 Million
Q3 2021 Nov 15, 2021	SELL	$25.71 - $35.24 $7.97 Million - $10.9 Million	-310,000 Reduced 93.94%	20,000 $525,000
Q2 2021 Aug 16, 2021	SELL	$30.1 - $34.85 $17.2 Million - $19.9 Million	-570,000 Reduced 63.33%	330,000 $10.3 Million
Q1 2021 May 17, 2021	BUY	$25.89 - $44.46 $5.78 Million - $9.92 Million	223,106 Added 32.96%	900,000 $27.6 Million
Q4 2020 Feb 16, 2021	SELL	$23.42 - $39.5 $7.03 Million - $11.9 Million	-300,000 Reduced 30.71%	676,894 $23.2 Million
Q3 2020 Nov 16, 2020	BUY	$21.55 - $33.92 $6.68 Million - $10.5 Million	310,000 Added 46.48%	976,894 $30.1 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $32.99 $20.5 Million - $22 Million	666,894 New	666,894 $20.3 Million

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $118M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.